Search hospitals > Tennessee > Knoxville
New Orleans Center for Clinical Research
Claim this profileKnoxville, Tennessee 37920
Global Leader in Primary Lateral Sclerosis
Global Leader in Type 2 Diabetes
Conducts research for Multiple Sclerosis
Conducts research for Diabetes Mellitus
Conducts research for Renal Disease
112 reported clinical trials
3 medical researchers
Summary
New Orleans Center for Clinical Research is a medical facility located in Knoxville, Tennessee. This center is recognized for care of Primary Lateral Sclerosis, Type 2 Diabetes, Multiple Sclerosis, Diabetes Mellitus, Renal Disease and other specialties. New Orleans Center for Clinical Research is involved with conducting 112 clinical trials across 166 conditions. There are 3 research doctors associated with this hospital, such as Evelyne M Davidson, Natalie L Clarke, and Davidson.Top PIs
Evelyne M DavidsonNew Phase Research and Development5 years of reported clinical research
Studies Chronic Obstructive Pulmonary Disease
Studies Obstructive Pulmonary Disease
8 reported clinical trials
13 drugs studied
Natalie L ClarkeNew Phase Research & Development4 years of reported clinical research
Studies Neuropathic Pain
Studies Chronic post-surgical pain
2 reported clinical trials
4 drugs studied
DavidsonNew Phase Research & Development3 years of reported clinical research
Studies Atherosclerosis
Studies Cardiovascular Disease
1 reported clinical trial
2 drugs studied
Clinical Trials running at New Orleans Center for Clinical Research
Multiple Sclerosis
Primary Lateral Sclerosis
Obesity
Diabetes Mellitus
Childhood Obesity
Type 2 Diabetes
Neuropathic Pain
Chronic Polyneuropathy
Nerve pain
Peripheral Neuropathy
Ofatumumab
for Multiple Sclerosis
This trial will test if patients with a specific type of multiple sclerosis benefit from switching to a new medication. The medication aims to reduce harmful cells in the nervous system, potentially preventing future issues. It has been approved in several countries for treating this condition.
Recruiting3 awards Phase 410 criteria
Remibrutinib vs Teriflunomide
for Multiple Sclerosis
This trial compares two medications, remibrutinib and teriflunomide, for treating patients with relapsing multiple sclerosis. These patients have repeated episodes of symptoms and need effective treatments. The medications work by controlling the immune system to prevent it from causing damage to the nervous system. Teriflunomide is an approved medication for adults with relapsing multiple sclerosis.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at New Orleans Center for Clinical Research?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.